Feryal Alhamadani

Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs

J. Manautou, R. Bahal, Xiao-bo Zhong, 2022, Drug Metabolism and Disposition.

Nephrotoxicity of marketed antisense oligonucleotide drugs.

J. Manautou, R. Bahal, Xiao-bo Zhong, 2022, Current opinion in toxicology.

Adverse Drug Reactions and Toxicity of the FDA-approved Antisense Oligonucleotide Drugs

J. Manautou, R. Bahal, Xiao-bo Zhong, 2022 .

Special Section on Pharmacokinetics and ADME of Biological Therapeutics — Minireview Adverse Drug Reactions and Toxicity of the Food and Drug Administration – Approved Antisense Oligonucleotide Drugs

R. Bahal, Xiao-bo Zhong, Rajvi Parikh, 2022 .